1. Hosie, A, Davidson, PM, Agar, M, et al. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med 2013; 27: 486–498.
Google Scholar | SAGE Journals | ISI2. Watt, CL, Momoli, F, Ansari, MT, et al. The incidence and prevalence of delirium across palliative care settings: a systematic review. Palliat Med 2019; 33: 865–877.
Google Scholar | SAGE Journals | ISI3. Salluh, JI, Wang, H, Schneider, EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015; 350: h2538.
Google Scholar | Crossref | Medline4. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association Publishing, 2014.
Google Scholar5. Inouye, SK. Delirium in hospitalized older patients: recognition and risk factors. J Geriatr Psychiatry Neurol 1998; 11: 118–125; discussion 157.
Google Scholar | SAGE Journals | ISI6. Siddiqi, N, Harrison, JK, Clegg, A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev 2016; 3: CD005563.
Google Scholar | Medline7. Hshieh, TT, Yue, J, Oh, E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med 2015; 175: 512–520.
Google Scholar | Crossref | Medline8. Ahmed, S, Leurent, B, Sampson, EL. Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis. Age Ageing 2014; 43(3): 326–333.
Google Scholar | Crossref | Medline | ISI9. Zaal, IJ, Devlin, JW, Peelen, LM, et al. A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015; 43: 40–47.
Google Scholar | Crossref | Medline | ISI10. Vasilevskis, EE, Han, JH, Hughes, CG, et al. Epidemiology and risk factors for delirium across hospital settings. Best Pract Res Clin Anaesthesiol 2012; 26: 277–287.
Google Scholar | Crossref | Medline11. Lawlor, PG, Davis, DHJ, Ansari, M, et al. An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives. J Pain Symptom Manag 2014; 48: 159–175.
Google Scholar | Crossref | Medline12. Lawlor, PG, Rutkowski, NA, MacDonald, AR, et al. A scoping review to map empirical evidence regarding key domains and questions in the clinical pathway of delirium in palliative care. J Pain Symptom Manag 2019; 57: 661–681.e12.
Google Scholar | Crossref | Medline13. Featherstone, I, Sheldon, T, Johnson, M, et al. A systematic review of risk factors for delirium in adult patients receiving specialist palliative care. PROSPERO: International prospective register of systematic reviews. 2019. Report no. CRD42019157168. Centre for Reviews and Dissemination, University of York.
Google Scholar14. Moher, D, Liberati, A, Tetzlaff, J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264–269, W64.
Google Scholar | Crossref15. Dekkers, OM, Vandenbroucke, JP, Cevallos, M, et al. COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med 2019; 16: e1002742.
Google Scholar | Crossref | Medline16. International Epidemiological Association . A dictionary of epidemiology. 6th ed. New York, NY: Oxford University Press, 2016.
Google Scholar17. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Association Publishing, 1980.
Google Scholar18. Rietjens, JA, Bramer, WM, Geijteman, EC, et al. Development and validation of search filters to find articles on palliative care in bibliographic databases. Palliat Med 2019; 33(4): 470–474.
Google Scholar | SAGE Journals | ISI19. Siddiqi, N, Clegg, A, Todd, OM, et al. Non-pharmacological interventions for managing delirium in hospitalised patients. Cochrane Database Syst Rev 2017, Issue 4. https://doi.org/10.1002/14651858.CD005995.pub2
Google Scholar20. Datla, S, Verberkt, CA, Hoye, A, et al. Multi-disciplinary palliative care is effective in people with symptomatic heart failure: a systematic review and narrative synthesis. Palliat Med 2019; 33: 1003–1016.
Google Scholar | SAGE Journals | ISI21. Veritas Health Innovation . Covidence systematic review software. Melbourne, Victoria, Australia: Veritas Health Innovation.
Google Scholar22. Microsoft Excel. Microsoft Corporation , 2018, https://office.microsoft.com/excel
Google Scholar23. Hayden, JA, van der Windt, DA, Cartwright, JL, et al. Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158: 280–286.
Google Scholar | Crossref | Medline | ISI24. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924–926.
Google Scholar | Crossref | Medline25. Higgins, JP, Thomas, J, Chandler, J, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester: John Wiley & Sons, 2019.
Google Scholar | Crossref26. Higgins, JPT, Thompson, SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
Google Scholar | Crossref | Medline | ISI27. Borenstein, M, Hedges, L, Higgins, J, et al. Introduction to meta-analysis. Chichester: John Wiley and Sons, 2009.
Google Scholar | Crossref28. Review Manager (RevMan) Computer Program. 5.4 ed. London: The Cochrane Collaboration, 2020.
Google Scholar29. Popay, J, Roberts, H, Sowden, A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. ESRC methods programme. Lancaster University. 2006.
Google Scholar30. Huguet, A, Hayden, JA, Stinson, J, et al. Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Syst Rev 2013; 2(1): 71.
Google Scholar | Crossref | Medline31. Foroutan, F, Guyatt, G, Zuk, V, et al. GRADE guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. J Clin Epidemiol 2020; 121: 62–70.
Google Scholar | Crossref | Medline32. Mercadante, S, Adile, C, Ferrera, P, et al. Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit. Curr Med Res Opin 2017; 33: 1303–1308.
Google Scholar | Crossref | Medline33. Mercadante, S, Masedu, F, Balzani, I, et al. Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after 1 week of palliative care. Support Care Cancer 2018; 26: 913–919.
Google Scholar | Crossref | Medline34. Mercadante, S, Adile, C, Ferrera, P, et al. Symptom expression in patients with advanced cancer admitted to an acute supportive/palliative care unit with and without delirium. Oncologist 2019; 24: e358–e364.
Google Scholar | Crossref35. Mercadante, S, Masedu, F, Maltoni, M, et al. Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium. Intern Emerg Med 2019; 14: 515–520.
Google Scholar | Crossref | Medline36. Cruz-Jentoft, AJ, Boland, B, Rexach, L. Drug therapy optimization at the end of life. Drugs Aging 2012; 29: 511–521.
Google Scholar | Crossref | Medline | ISI37. De la Cruz, M, Ransing, V, Yennu, S, et al. The frequency, characteristics, and outcomes among cancer patients with delirium admitted to an acute palliative care unit. Oncologist 2015; 20: 1425–1431.
Google Scholar | Crossref | Medline38. de la Cruz, M, Yennu, S, Liu, D, et al. Increased symptom expression among patients with delirium admitted to an acute palliative care unit. J Palliat Med 2017; 20(6): 638–641.
Google Scholar | Crossref | Medline39. Spiller, JA, Keen, JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006; 20: 17–23.
Google Scholar | SAGE Journals | ISI40. Braiteh, F, El Osta, B, Palmer, JL, et al. Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 2007; 10: 948–955.
Google Scholar | Crossref | Medline | ISI41. Fadul, NA, El Osta, B, Dalal, S, et al. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 2008; 11: 422–427.
Google Scholar | Crossref | Medline | ISI42. Sarhill, N, Walsh, D, Nelson, KA, et al. Assessment of delirium in advanced cancer: the use of the bedside confusion scale. Am J Hosp Palliat Care 2001; 18: 335–341.
Google Scholar | SAGE Journals43. Slatore, CG, Goy, ER, Oʼhearn, DJ, et al. Sleep quality and its association with delirium among veterans enrolled in hospice. Am J Geriatr Psychiatr 2012; 20: 317–326.
Google Scholar | Crossref | Medline | ISI44. Stillman, MJ, Rybicki, LA. The bedside confusion scale: development of a portable bedside test for confusion and its application to the palliative medicine population. J Palliat Med 2000; 3: 449–456.
Google Scholar | Crossref | Medline45. Zimmerman, KM, Salow, M, Skarf, LM, et al. Increasing anticholinergic burden and delirium in palliative care inpatients. Palliat Med 2014; 28: 335–341.
Google Scholar | SAGE Journals | ISI46. Matsuoka, H, Yoshiuchi, K, Koyama, A, et al. Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients. Palliat Support Care 2015; 13: 859–864.
Google Scholar | Crossref | Medline47. Morita, T, Tsunoda, J, Inoue, S, et al. [Risk factors of delirium in terminally ill cancer patients: a prospective study]. Seishin Igaku 1998; 40: 823–829.
Google Scholar48. Minagawa, H, Uchitomi, Y, Yamawaki, S, et al. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer 1996; 78: 1131–1137.
Google Scholar | Crossref | Medline | ISI49. Matsuo, N, Morita, T, Matsuda, Y, et al. Predictors of delirium in corticosteroid-treated patients with advanced cancer: an exploratory, multicenter, prospective, observational study. J Palliat Med 2017; 20: 352–359.
Google Scholar | Crossref | Medline50. Caraceni, A, Nanni, O, Maltoni, M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian multicenter study group on palliative care. Cancer 2000; 89: 1145–1149.
Google Scholar | Crossref | Medline | ISI51. Barahona, E, Pinhao, R, Galindo, V, et al. The diagnostic sensitivity of the Memorial delirium assessment scale-spanish version. J Pain Symptom Manag 2018; 55: 968–972.
Google Scholar | Crossref | Medline52. Díaz García, V, López Pérez, M, Zuriarrain Reyna, Y. Prevalencia de delirium mediante la escala Memorial Delirium Assessment Scale (MDAS) en pacientes oncologicos avanzados ingresados en una Unidad de Cuidados Paliativos. Factores de riesgo, reversibilidad y tratamiento recibido [Prevalence of delirium using the Memorial Delirium Assessment Scale (MDAS) in advanced oncology patients admitted to a palliative care unit. Risk factors, reversibility and treatment received]. Med Paliativa 2018; 25: 245–254.
Google Scholar | Crossref53. Farriols Danés, C, Landa Teran, CP, Ruiz Ripoll, AI, et al. Prevalencia del delirium en pacientes con enfermedad oncologica avanzada ingresados en una unidad de cuidados paliativos [Prevalence of delirium in patients with advanced cancer admitted to a palliative care unit]. Med Paliativa 2016; 23: 165–171.
Google Scholar |